Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 22, Issue 1, 2012, Pages 16-25

  Akima, Hiroshi ^a,b   Lott, Donovan ^a   Senesac, Claudia ^a   Deol, Jasjit ^a   Germain, Sean ^a   Arpan, Ishu ^a   Bendixen, Roxanna ^a   Lee Sweeney, H ^c   Walter, Glenn ^a   Vandenborne, Krista ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NAGOYA UNIVERSITY   (Japan)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Duchenne muscular dystrophy; Magnetic resonance imaging; Muscle strength

Indexed keywords

ARTICLE; BICEPS BRACHII MUSCLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECTUS FEMORIS MUSCLE; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CHILD; DISEASE PROGRESSION; HUMANS; LOWER EXTREMITY; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; THIGH; TORQUE;

EID: 84855990301     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.06.750     Document Type: Article

References (36)

1. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
2. Kapsa R., Kornberg A.J., Byrne E. Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2003, 2:299-310.
3. Tidball J.G., Spencer M.J. Skipping to new gene therapies for muscular dystrophy. Nat Med 2003, 9:997-998.
4. Liu G.-C., Jong Y.-J., Chiang C.-H., Jaw T.-S. Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 1993, 186:475-480.
5. Liu M., Chino H., Ishihara T. Muscle damage progression in Duchenne muscular dystrophy evaluated by a new quantitative computed tomography method. Arch Phys Med Rehabil 1993, 73:507-514.
6. McDonald C.M., Abresch R.T., Carter G.T., et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995, 74(Suppl. 5):S70-S92.
7. Mercuri E., Pichiecchio A., Allsop J., et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007, 25:433-440.
8. Marden F.A., Connolly A.M., Siegel M.J., Rubin D.A. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 2005, 34:140-148.
9. Wren T.A.L., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. Am J Roentgenol 2009, 190:W8-W12.
10. Mathur S., Lott D., Senesac C., et al. Age-related differences in lower limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2010, 91:1051-1058.
11. Phoenix J., Betal D., Roberts N., Helliwell T.R., Edward R.H.T. Objective quantification of muscle and fat in humans dystrophy muscle by magnetic resonance image analysis. Muscle Nerve 1996, 19:302-310.
12. Akima H., Kubo K., Imai M., et al. Inactivity and muscle: effect of resistance training during bed rest on muscle size in the lower limb. Acta Physiol Scand 2001, 172:269-278.
13. Akima H., Kano Y., Enomoto Y., et al. Muscle function in 164 men and women aged 20 to 84 yrs. Med Sci Sports Exerc 2001, 33:220-226.
14. Elder C.P., Apple D.F., Bickel S.C., Meyer R.A., Dudley G.A. Intramuscular fat and glucose tolerance after spinal cord injury - a cross-sectional study. Spinal Cord 2004, 42:711-716.
15. Gorgey A.S., Dudley G.A. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord 2007, 45:304-309.
16. Kent-Braun J.A., Ng A.V., Young H. Skeletal muscle contractile and noncontractile components in young and older women and men. J Appl Physiol 2000, 88:662-668.
17. Manini T.M., Clark B.C., Goodpaster B.H., Ploutz-Snyder L.L., Harris T.B. Reduced physical activity increases intermuscular adipose tissue in health young adults. Am J Nutr 2007, 85:377-384.
18. Sled J.G., Zijdenbos A.P. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998, 17:87-97.
19. Sezgin M., Sankur B. Survey over image thresholding techniques and quantitative performance evaluation. J Electro Imaging 2004, 13:146-165.
20. Kanehisa H., Ikegawa S., Tsunoda N., Fukunaga T. Strength and cross-sectional area of knee extensor muscles in children. Eur J Appl Physiol 1994, 68:402-405.
21. Brookes M.H., Griggs R.C., Mendell J.R., et al. Clinical trials in Duchenne dystrophy. I: The design of the protocol. Muscle Nerve 1981, 4:186-197.
22. Fukunaga T., Miyatani M., Tachi M., et al. Muscle volume is a major determinant of joint torque in humans. Acta Physiol Scand 2001, 172:249-255.
23. Skalsky A.J., Han J.J., Abresch R.T., Shin C.S., McDonald C.M. Assessment of regional body composition with dual-energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve 2009, 39:647-651.
24. Fukunaga T., Roy R.R., Shellock F.G., Hodgson J.A., Edgerton V.R. Specific tension of human plantar flexors and dorsiflexors. J Appl Physiol 1996, 80:158-165.
25. O'Brien T.D., Reeves N.D., Baltzopoulos V., Jones D.A., Maganaris C.N. In vivo measurements of muscle specific tension in adults and children. Exp Physiol 2010, 95:202-210.
26. Denti M.A., Rosa A., D'Antona G., et al. Body-wide gene therapy of Duchenne muscular dystrophy in the mdx model. Proc Natl Acad Sci USA 2006, 103:3758-3763.
27. Lynch G.S., Hinkle R.T., Chamberlain J.S., Brooks S.V., Faulkner J.A. Force and power output of fast and slow skeletal muscles from mdx mice 6-28months old. J Physiol (Lond) 2001, 535:591-600.
28. Sampaolesi M., Blot S., D'Antona G., et al. Mesaangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006, 4444:574-579.
29. Krivickas L.S., Ansved T., Suh D., Frontera W.R. Contractile properties of single muscle fibers in myotonic dystrophy. Muscle Nerve 2000, 23:529-537.
30. Canepari M., Pellegrino M.A., D'Antona G., Bottinelli R. Skeletal muscle fibre diversity and the underlying mechanisms. Acta Physiol 2010, 199:465-476.
31. Kanehisa H., Yata H., Ikegawa S., Fukunaga T. A cross-sectional study of the size and strength of the lower leg muscles during growth. Eur J Appl Physiol Occup Physiol 1995, 72:150-156.
32. Neu C.M., Rauch F., Rittweger J., Manz F., Schoenau E. Influence of puberty on muscle development at the forearm. Am J Physiol Endocrinol Metab 2002, 283:E103-E107.
33. Lexell J., Sjöström M., Nordlund A.S., Taylor C.C. Growth and development of human muscle: a quantitative morphological study of whole vastus lateralis from childhood to adult age. Muscle Nerve 1992, 15:404-409.
34. Banks G.B., Chamberlain J.S., Froehner S.C. Truncated dystrophins can influence neuromuscular synapse structure. Mol Cell Neurosci 2009, 40:433-441.
35. Pilgram G.S.K., Potikanond S., Baines R.A., Frandkin L.G., Noordermeer J.N. The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol 2010, 41:1-21.
36. Nicholson L.V.B., Johnson M.A., Bushby K.M.D., et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1: Trends across the clinical groups. J Med Genet 1993, 30:728-736.